Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Attack; Control; Medical record; Observational; Risk factor; ICS; Inhaled corticosteroid; LABA; Long-acting β2 agonist; OCS; Oral corticosteroid; OPCRD; Optimum Patient Care Research Database;
مقالات ISI کورتیکواستروئیدهای استنشاقی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کورتیکواستروئیدهای استنشاقی; Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; direct costs; indirect costs; national asthma program; public health; ICS; Inhaled corticosteroid; LABA; Long-acting β2-agonist; SII; Finnish Social Insurance Institution;
Keywords: کورتیکواستروئیدهای استنشاقی; aerosols; asthma; COPD; inhalers; small airways; small particles; BDP; beclomethasone dipropionate; CFC; chlorofluorocarbon; DPI; dry powder inhaler; GSD; geometric standard deviation; HFA; hydrofluoroalkane; ICS; inhaled corticosteroid; LABA; long-acting
Keywords: کورتیکواستروئیدهای استنشاقی; Adenosine 5-monophosphate; Asthma; Bronchial hyperresponsiveness; Children; Inhaled corticosteroid; ICS; inhaled corticosteroid; BHR; bronchial hyperresponsiveness; eNO; exhaled nitric oxide; FEV1; forced expiratory volume in one second; FVC; forced vital
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Step-down; Long acting beta agonists; Pulmonary function; Inhaled corticosteroid;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Adult-onset; Asthma duration; Childhood-onset; Elderly; Inflammatory biomarker; ACQ; Asthma control questionnaire; AQLQ; Asthma quality of life questionnaire; ATS; American Thoracic Society; BMI; Body mass index; BTS; British Thoracic Society; CAP
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; small airways; spirometry; impulse oscillometry; long-acting β-agonist; formoterol; salmeterol; ACQ; Asthma Control Questionnaire; AX; Reactance area under the curve; FEF25-75; Forced midexpiratory flow between 25% and 75% of forced vital capacit
Keywords: کورتیکواستروئیدهای استنشاقی; Inhaled corticosteroids; Adherence; medication; asthma; African Continental Ancestry Group; respiratory function tests; ACT; Asthma Control Test; BMI; Body mass index; ICS; Inhaled corticosteroid; SAPPHIRE; Study for Asthma Phenotypes and Pharmacogenomic
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; biomarkers; eosinophil; IgE; periostin; nitric oxide; Feno; Fraction of exhaled nitric oxide; ICS; Inhaled corticosteroid;
Keywords: کورتیکواستروئیدهای استنشاقی; Medication adherence; Implementation; Initiation; Persistence; Elderly patients; Childhood asthma; Adolescents; Cognitive impairment; COPD; chronic obstructive pulmonary disease; ICS; inhaled corticosteroid;
Keywords: کورتیکواستروئیدهای استنشاقی; Asma; Broncodilatador; Fluticasona propionato; Formoterol fumarato; Glucocorticoides inhalados; Agonista β2-adrenérgico de acción largaAsthma; Bronchodilator; Fluticasone propionate; Formoterol fumarate; Inhaled corticosteroid; Long-acting β2-agonist
Keywords: کورتیکواستروئیدهای استنشاقی; Severe asthma; Children; Lung function; Phenotype; Endotype; Inflammation; ATS; American Thoracic Society; FEV1; Forced expiratory volume in one second; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; IgE; Immunoglobulin E; RV; Residual volume; S
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; small airways; acinus; physiology; ACQ; Asthma Control Questionnaire; ADC; Apparent diffusion coefficient; CDI; Convection-dependent inhomogeneity; CT; Computed tomography; DCDI; Diffusion-convection-dependent inhomogeneity; FRC; Functional resi
Keywords: کورتیکواستروئیدهای استنشاقی; Chronic obstructive pulmonary disease; Exacerbation; Inhaled corticosteroid; Systemic corticosteroid; COPD; chronic obstructive pulmonary disease; AECOPD; acute exacerbations of chronic obstructive pulmonary disease; SC; systemic corticosteroid; IC; inhal
Keywords: کورتیکواستروئیدهای استنشاقی; Exhaled nitric oxide; blood eosinophil count; asthma control; lung function; bronchial responsiveness; ACT; Asthma Control Test; ATS; American Thoracic Society; BHR; Bronchial hyperresponsiveness; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; ambient air pollution; airway hyperresponsiveness; inhaled corticosteroids; lung function; AHR; Airway responsiveness; CAMP; Childhood Asthma Management Program; CO; Carbon monoxide; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; IQR; In
Keywords: کورتیکواستروئیدهای استنشاقی; asthma; inhaled corticosteroids; interferon; neutrophil; rhinovirus; ACQ6; asthma control questionnaire 6; CXCL; C-X-C motif ligand; ELISA; enzyme-linked immunosorbent assay; HRV; human rhinovirus; ICS; inhaled corticosteroid; IFN; interferon; PBMC; perip
Keywords: کورتیکواستروئیدهای استنشاقی; ICS; inhaled corticosteroid; Cys-LTs; cysteinyl leukotrienes; EBC; exhaled breath condensate; PEF; peak expiratory flow rate; FEV1; forced expiratory volume in first second; ELISA; enzyme linked immunoassay; FP; fluticasone propionate; P; oral prednisone;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; microbiome; corticosteroids; FEV1; bacteria; 16S ribosomal RNA; BAL; Bronchoalveolar lavage; EB; Endobronchial brushing; FDR; False discovery rate; GLM; Generalized linear regression model; ICS; Inhaled corticosteroid; OCS; Oral corticosteroid; OT
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; asthma severity; fibrocytes; peripheral blood; biomarker; APC; Allophycocyanin; ATS; American Thoracic Society; Col1; Collagen 1; EGFR; Epithelial growth factor receptor; FACS; Fluorescence-activated cell sorting; FVC; Forced vital capacity; GINA;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; small airways; FEF25-75; epidemiology; longitudinal; BHR; Bronchial hyperresponsiveness; EGEA; Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy; FEF25-75; Forced midexpiratory flow between 2
Keywords: کورتیکواستروئیدهای استنشاقی; Pediatric; severe asthma; steroid response; spirometry; inflammation; ACT; Asthma Control Test; BAL; Bronchoalveolar lavage; BDR; Bronchodilator reversibility; Feno; Fraction of exhaled nitric oxide; ICS; Inhaled corticosteroid; STRA; Severe therapy-resis
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; chronic obstructive pulmonary disease; asthma-chronic obstructive pulmonary disease overlap syndrome; definition; prevalence; ACOS; Asthma-COPD phenotype or overlap syndrome; COPD; Chronic obstructive pulmonary disease; GINA; Global Initiative f
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; asthma treatment; asthma biomarkers; asthma phenotype; inhaled corticosteroid; leukotriene receptor antagonist; personalized medicine; treatment response; ACD; Asthma control day; ECP; Eosinophil cationic protein; ICS; Inhaled corticosteroid; INFA
Keywords: کورتیکواستروئیدهای استنشاقی; Adults; asthma; health disparities; health literacy; inhaled corticosteroids; minority groups; numeracy; print literacy; self-management; ANQ; Asthma Numeracy Questionnaire; DPI; Dry powder inhaler; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler;
Keywords: کورتیکواستروئیدهای استنشاقی; asthma; eosinophil; phase 3; reslizumab; ACQ; Asthma Control Questionnaire; ADA; anti-drug antibody; AE; adverse event; FAS; full analysis set; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; LS; least squares; SABA; short-acting β-agonist;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Pre-school wheeze; Allergic rhinitis; Leukotriene; Inhaled corticosteroid
Keywords: کورتیکواستروئیدهای استنشاقی; Bronchial provocation test; Fraction of exhaled NO; IgE; Inhaled corticosteroid; Pulmonary function testing
Keywords: کورتیکواستروئیدهای استنشاقی; Microbiome; microbiota; bacterial community composition; immune function; allergy; asthma; ICS; Inhaled corticosteroid; OVA; Ovalbumin; Treg; Regulatory T;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; severe asthma; severe refractory asthma; difficult-to-control asthma; prevalence; ACQ; Asthma Control Questionnaire; COPD; Chronic obstructive pulmonary disease; ICS; Inhaled corticosteroid; IMI; Innovative Medicine Initiative; LABA; Long-acting Î
Keywords: کورتیکواستروئیدهای استنشاقی; ADHD; Attention deficit hyperactivity disorder; CFC; Chlorofluorocarbon; FDA; Food and Drug Administration; HFA; Hydrofluoroalkane; ICS; Inhaled corticosteroid; SSRI; Selective serotonin reuptake inhibitor;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Inhaled steroids; Smokers; Sputum mediators; Statins; ACQ; asthma control questionnaire; AQLQ; asthma quality of life questionnaire; ATS; American Thoracic Society; BMI; body mass index; CCL; chemokine (C-C motif) ligand; CXCL; chemokine (C-X-C mo
Keywords: کورتیکواستروئیدهای استنشاقی; Systemic corticosteroids; severe asthma; health care use; dose response; corticosteroid-related complications; cost; CCI; Charlson Comorbidity Index; GEE; Generalized estimating equation; ICD-9-CM; International Classification of Diseases, Ninth Revision,
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; adults; inhaled corticosteroids; asthma management; AERD; Aspirin-exacerbated respiratory disease; CLCA1; Calcium-activated chloride channel regulator 1; COPD; Chronic obstructive pulmonary disease; Feno; Fraction of exhaled nitric oxide; GP; Gene
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; asthma control; quality of life; network meta-analysis; questionnaire; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist;
Keywords: کورتیکواستروئیدهای استنشاقی; 11β-PGF2α; 11β-prostaglandin F2α; BHR; bronchial hyperresponsiveness; DHA; docosahexaenoic acid; EIB; exercise-induced bronchoconstriction; EPA; eicosapentaenoic acid; EVH; eucapnic voluntary hyperventilation; HEPE; hydroxyeicosapentaenoic acid; ICS;
Keywords: کورتیکواستروئیدهای استنشاقی; ACQ-7; Asthma Control Questionnaire 7; AE; adverse event; AQLQ; Asthma Quality of Life Questionnaire; ICS; inhaled corticosteroid; LABA; long-acting β2-agonist; MCID; minimal clinically important difference; NNTB; number needed to treat for benefit; OD;
Keywords: کورتیکواستروئیدهای استنشاقی; BSG; bismuth subgallate; ICS; inhaled corticosteroid; SPS; sodium polystyrene sulfonate; TEF; tracheoesophageal fistula;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; chronic obstructive pulmonary disease; Dutch hypothesis; allergy; hyperresponsiveness; ACOS; Asthma and COPD overlap syndrome; BHR; Bronchial hyperresponsiveness; COPD; Chronic obstructive pulmonary disease; CT; Computed tomography; GWAS; Genome-w
Keywords: کورتیکواستروئیدهای استنشاقی; Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-adrenergic agonists; personalized medicine; severe
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Inhaled corticosteroid; Bronchodilator; Long-acting β2 agonist
Keywords: کورتیکواستروئیدهای استنشاقی; aOR; adjusted OR; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; OCS; oral corticosteroid; PEF; peak expiratory flow;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; Pediatric; Inhaled corticosteroid; Stratified analysis; ACD; Asthma control day; HR; Hazard ratio; TFE; Time to first exacerbation; TREXA; Treating Children to Prevent Exacerbations of Asthma;
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; T lymphocytes; cytokines; mast cells; phenotype; endotype; regulatory T; TH17; TH2; mucosal-associated invariant T-cell; ACQ; Asthma Control Questionnaire; BAL; Bronchoalveolar lavage; BNA; Bayesian network analysis; eNO; Exhaled nitric oxide; FOX
Keywords: کورتیکواستروئیدهای استنشاقی; Pregnancy; Asthma; Anti-asthmatic agents; Congenital abnormalities; Electronic medical records; Teratogens; BDP; Beclometasone dipropionate; CPRD; Clinical Practice Research Datalink; FP; Fluticasone propionate; FSC; Fluticasone propionate in fixed dose c
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma phenotypes; biologic therapies; eosinophils; IgE; IL-4; IL-5; IL-13; TH2/type 2 inflammation; ACQ; Asthma Control Questionnaire; DBPC; Double-blind, placebo-controlled; FDA; US Food and Drug Administration; Feno; Fraction of exhaled nitric oxide; I
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; asthma control; budesonide/formoterol maintenance and reliever therapy; exacerbations; Global Initiative for Asthma; predictors; risk score; ACQ-5; 5-Item Asthma Control Questionnaire; ADAS; Asthma Disease Activity Score; BMI; Body mass index; BUD
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; asthma control; asthma exacerbations; dupilumab; biomarkers; inhaled corticosteroids; lebrikizumab; long-acting Ã-adrenergic agonists; mepolizumab; omalizumab; reslizumab; severe asthma; therapeutics; ACQ; Asthma control questionnaire; BADGER; Be
Keywords: کورتیکواستروئیدهای استنشاقی; Asthma; seasons; biomarkers; asthma exacerbations; IgE; exhaled nitric oxide; allergy; eosinophils; pulmonary function; ACE; Asthma Control Evaluation; BMI; Body mass index; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital capacity; ICATA; Inner